Hypothesis

We propose that glucosepane buildup in stromal collagen impairs integrin‑β1 mechanotransduction, triggering keratocyte senescence via p16^INK4a upregulation and a secretory phenotype that further disrupts collagen organization.

Mechanistic Basis

• It's known that glucosepane forms non‑reducible cross‑links that stiffen fibrils, altering the nanoscale rigidity sensed by keratocyte integrins (Human corneal keratocyte density declines linearly at approximately 0.3–0.45% per year).
• Increased matrix rigidity shifts focal adhesion kinase (FAK) signaling toward a pro‑senescent state, raising nuclear p16^INK4a and lowering proliferative capacity (The aging stroma exhibits increased collagen cross‑linking, fibril disorganization, thinning, and nerve fiber loss, disrupting transparency and biomechanics).
• Senescent keratocytes release matrix metalloproteinases and TGF‑β isoforms that degrade ordered lamellae and encourage aberrant fibril bundling, creating a feed‑forward loop of disorganization.
• This mechanistic link explains why metabolic improvements (e.g., after bariatric surgery) can partially restore keratocyte density (Keratocyte density reductions in severe obesity can partially reverse following bariatric surgery): reduced systemic glucose flux lowers glycation and glucosepane formation.

Testable Predictions

1. In donor corneas grouped by age, glucosepane levels will positively correlate with p16^INK4a+ keratocyte density and negatively correlate with regular collagen fibril spacing measured by second‑harmonic generation.
2. Applying a glucosepane‑cleaving agent (e.g., N‑phenacylthiazolium bromide) to cultured stromal explants will decrease p16^INK4a expression and rescue collagen lattice order after seven days.
3. Keratocytes isolated from high‑glucosepane stroma will display elevated FAK phosphorylation and SASP markers, which are reduced by integrin‑β1 blocking antibodies.

Experimental Approach

• We'll collect cadaveric human corneas spanning decades (n≥30 per decade). Measure glucosepane via LC‑MS/MS, keratocyte senescence with immunofluorescence for p16^INK4a and SA‑β‑gal, and collagen organization using synchrotron‑based small‑angle X‑ray scattering.
• Treat stromal explants with a glucosepane breaker or vehicle, then assess keratocyte proliferation (Ki‑67), collagen fibril diameter distribution (electron microscopy), and light transmission (spectrophotometry).
• Use siRNA against integrin‑β1 in primary keratocytes to test whether mechanotransduction blockade mimics glucosepane effects.

If glucosepane‑driven mechanotransduction failure drives stromal aging, lowering its accumulation should uncouple keratocyte loss from collagen disorganization, preserving transparency even in old tissue.